Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NDI

Financiado

Cerrado

Nano diamond tracers for MRI molecular imaging

"Molecular imaging is the current standard of care for the diagnosis (staging) of cancer, the evaluation of cancer treatment effectiveness, and is generating evidence as the best predictor for earlier diagnosis of Alzheimer’s dise... ver más

31/05/2016

UULM

148K€

Presupuesto del proyecto: 148K€

Líder del proyecto

UNIVERSITAET ULM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2016-05-31

ERC-PoC-2014: ERC Proof of Concept Grant Scope:Objectives

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

UULM

147.50K€ | Lider

DIMEC DISENO,

412.56K€ | Participante

Proyectos interesantes

NANOSMARTS

Medical Technol...

Nanotechnology

15K€ Cerrado

PCI2023-143369

Medical Technol...

Nanotechnology

218K€ Cerrado

NANOSMARTS

Medical Technol...

Nanotechnology

157K€ Cerrado

PDC2022-133493-I00

Medical Technol...

Nanotechnology

150K€ Cerrado

RBCE-GENODIAGNOSENS

Medical Technol...

Nanotechnology

159K€ Cerrado

PCIN-2015-098

Medical Technol...

Nanotechnology

115K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 18 meses Fecha Inicio: 2014-11-28
Fecha Fin: 2016-05-31

Líder del proyecto

UNIVERSITAET ULM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 148K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Molecular imaging is the current standard of care for the diagnosis (staging) of cancer, the evaluation of cancer treatment effectiveness, and is generating evidence as the best predictor for earlier diagnosis of Alzheimer’s disease. Molecular imaging differs from traditional imaging in that probes known as biomarkers are used to help image particular pathways. The goal is to image injected bio-active molecules (biomarkers) in vivo, allowing targeted imaging of the processes these molecules participate in. Currently, the most common clinical modality for molecular imaging is Positron Emission Tomography (PET), a nuclear imaging method with high costs that exposes patients to potentially harmful radiation. It is currently impossible to perform molecular imaging with magnetic resonance imaging (MRI) scanners due to low molecular sensitivity. Our primary goal is the development and commercialization of a novel technology for molecular imaging using existing MRI scanners, which could dramatically improve the early diagnosis of cancer and Alzheimer's disease, and serve as a platform for future medical research. We will develop a new ""tracer"" agent for MRI, using nano-diamonds. Using a novel polarization scheme, as well as 13C enriched diamonds, we increase the nano-diamond MRI signal more than a 10,000,000-fold at room temperature. This will provide a solution for molecular imaging which is cheaper, does not expose patients to ionized radiation, and allows earlier diagnosis of cancer metastasis due to the superior spatial resolution of MRI. The proposed project aims to bring this idea to the proof-of-concept level by demonstrating the imaging of cancerous tumors in a biological model, using an industrial MRI scanner and nano-diamond tracers. In parallel, we will also develop our future regulatory strategy, explore the market potential and secure potential customers. Ultimately, we intend to launch a company to bring this product to market."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores